Literature DB >> 21338180

Long-term survival of cancer patients in Korea, 1993-2007: National Cancer Registry Study.

Joo Young Lee1, Kyu-Won Jung, Sohee Park, Hyun-Joo Kong, Young-Joo Won, Hai-Rim Shin, Eun-Cheol Park, Jin-Soo Lee.   

Abstract

Although survival rates are very useful for monitoring the effects of early cancer detection and treatment, at present there are only limited population-based estimates of long-term survival rates in Korea. Furthermore, published data are only available for 5-year survival; 10-year survival rates have hitherto not been reported. We therefore analysed data from the Korean National Cancer Incidence Database between 1993 and 2007 and followed through into 2008 to estimate long-term survival rates and trends at 5 and 10 years after diagnosis of all cancers combined. Further analysis was conducted on the 19 most common cancers in Korea. From 1993 to 2007, the 10-year relative survival rates (RSRs) for all cancer types combined were 36.3% and 56.4% in Korean men and women, respectively. The 10-year RSRs for all cancers combined improved from 29.5% and 50.5% during 1993-1998 to 39.2% and 58.9% during 1999-2007 in Korean men and women, respectively. From 1993 to 2007, the 5-year and 10-year RSRs thus improved in both sexes for the most common cancers. In the 75 years and older group, increases of the 5-year and 10-year RSR for all combined, and for most of the major cancers were lower than all other age groups. This study provides population-based estimates of long-term survival and confirms improvements of long-term survivals for all cancer sites and for most of the major cancer sites. Improvements of survival for young patients are more significant than for older patients. The results may help clinicians and patients assess long-term prognosis.

Entities:  

Mesh:

Year:  2010        PMID: 21338180

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  3 in total

1.  Cancer survival in Qidong between 1972 and 2011: A population-based analysis.

Authors:  Jian-Guo Chen; Jian Zhu; Yong-Hui Zhang; Yi-Xin Zhang; Deng-Fu Yao; Yong-Sheng Chen; Jian-Hua Lu; Lu-Lu Ding; Hai-Zhen Chen; Chao-Yong Zhu; Li-Ping Yang; Yuan-Rong Zhu; Fu-Lin Qiang
Journal:  Mol Clin Oncol       Date:  2017-05-03

2.  Improved long-term survival of corpus cancer in Japan: A 40-year population-based analysis.

Authors:  Asami Yagi; Yutaka Ueda; Sayaka Ikeda; Ai Miyoshi; Satoshi Nakagawa; Kosuke Hiramatsu; Eiji Kobayashi; Toshihiro Kimura; Yuri Ito; Tomio Nakayama; Kayo Nakata; Toshitaka Morishima; Isao Miyashiro; Tadashi Kimura
Journal:  Int J Cancer       Date:  2021-09-15       Impact factor: 7.316

3.  Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data.

Authors:  Yuri Ito; Isao Miyashiro; Hidemi Ito; Satoyo Hosono; Dai Chihara; Kayo Nakata-Yamada; Masashi Nakayama; Masashi Matsuzaka; Masakazu Hattori; Hiromi Sugiyama; Isao Oze; Rina Tanaka; Etsuko Nomura; Yoshikazu Nishino; Tomohiro Matsuda; Akiko Ioka; Hideaki Tsukuma; Tomio Nakayama
Journal:  Cancer Sci       Date:  2014-10-18       Impact factor: 6.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.